Media contacts

Iryna Mazur
+41 79 429 3671
+41 22 909 2920
imazur@gavi.org

Iryna Mazur

 

Meghana Sharafudeen
+41 79 711 5554
msharafudeen@gavi.org
 

Meghana Sharafudeen

 

Evan O’Connell
+33 6 17 57 21 26
+41 22 909 6528
eoconnell@gavi.org

Evan O’Connell

 

Laura Shevlin
+ 41 79 529 92 87
lshevlin@gavi.org
 

Laura Shevlin

Latest news releases

View all

Today, the governments of Côte d’Ivoire and Ghana began COVID-19 vaccination campaigns aimed at protecting healthcare workers

COVAX announces 600,000 doses of the AstraZeneca/Oxford vaccine licensed to Serum Institute of India have arrived in Accra, Ghana; further deliveries to Abidjan, Cote d’Ivoire are expected this week.

New programme makes compensation available to eligible individuals in 92 low- and middle-income countries without need to resort to law courts.

Today G7 leaders announced a doubling of funding for Gavi COVAX AMC to support lower-income economies obtain life-saving vaccines against COVID-19, ensuring greater equity in fighting to end the acute phase of the pandemic.

The signed memorandum of understanding (MoU) between Gavi and Novavax is to make a cumulative volume of 1.1 billion doses of the Novavax vaccine candidate available to the COVAX Facility.

Media resources | assets

If you would you like to receive updates from the Gavi media team, or request access to our digital library of high-resolution images and B-roll, please email media@gavi.org.

Facts and figures

GAVI/2017/Guido Dingemans/Mozambique

Gavi factsheet: about the Vaccine Alliance

Gavi factsheet: about the Vaccine Alliance

Types of support

GAVI/2017/Juliette Bastin/Burkina Faso

Country hub

Country hub

Gavi leadership

 

José Manuel Barroso
Board Chair

José Manuel Barroso

Dr Seth Berkley
CEO

Seth Berkley, Gavi CEO. Credit: Gavi/Oscar Seijkens.

Anuradha Gupta
Deputy CEO

Anuradha Gupta
Last updated: 18 Feb 2021

Subscribe to our newsletter